Variant report
Variant | nsv1052183 |
---|---|
Chromosome Location | chr13:64424127-64475455 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000214026 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs528621947 | chr13:64429412-64429413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs9598632 | chr13:64429455-64429456 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs565842799 | chr13:64429472-64429473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs190023261 | chr13:64429495-64429496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs535843139 | chr13:64429520-64429521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146520086 | chr13:64429631-64429632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs139993223 | chr13:64429693-64429694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs533608393 | chr13:64429713-64429714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs377170114 | chr13:64429732-64429733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs569544493 | chr13:64429752-64429753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs553552123 | chr13:64429762-64429763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs569339716 | chr13:64429780-64429781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs578091586 | chr13:64429821-64429822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs539351153 | chr13:64429840-64429841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs557358570 | chr13:64429852-64429853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs575640223 | chr13:64429863-64429864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575858142 | chr13:64429866-64429867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs9888457 | chr13:64429867-64429868 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs182526070 | chr13:64429877-64429878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs573399104 | chr13:64429891-64429892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs79146984 | chr13:64429894-64429895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs548424882 | chr13:64429945-64429946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs373050001 | chr13:64429958-64429959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs551938550 | chr13:64430022-64430023 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs556065 | chr13:64430033-64430034 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs140283224 | chr13:64430067-64430068 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs150328153 | chr13:64430097-64430098 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs562644340 | chr13:64430102-64430103 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs188386402 | chr13:64430148-64430149 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs534299275 | chr13:64430184-64430185 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs146582506 | chr13:64430190-64430191 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs377596932 | chr13:64430191-64430192 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs76063859 | chr13:64430202-64430203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs75204079 | chr13:64430232-64430233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs551967056 | chr13:64430260-64430261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs571847972 | chr13:64430273-64430274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs538852913 | chr13:64430312-64430313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs557481011 | chr13:64430386-64430387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs192752699 | chr13:64430387-64430388 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs536919952 | chr13:64430393-64430394 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs555034197 | chr13:64430413-64430414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs183141543 | chr13:64430446-64430447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs540761730 | chr13:64430554-64430555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs188418294 | chr13:64430597-64430598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs577221199 | chr13:64430632-64430633 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs76584132 | chr13:64430697-64430698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs76812389 | chr13:64430717-64430718 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs370132670 | chr13:64430752-64430753 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs544903071 | chr13:64430767-64430768 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs562667475 | chr13:64430791-64430792 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 22522925 | CNVD |
Melanoma | 20688739 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:64429400-64430200 | Enhancers | HepG2 | liver |
2 | chr13:64429600-64429800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr13:64429600-64430000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr13:64430000-64431000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr13:64430000-64431600 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr13:64430000-64436000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr13:64431000-64433200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr13:64431600-64432400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr13:64432400-64438600 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr13:64433200-64438800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr13:64434000-64434400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr13:64434200-64434600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
13 | chr13:64434400-64434800 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
14 | chr13:64434600-64436000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
15 | chr13:64438600-64440000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
16 | chr13:64438800-64440200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |